ARWR
ARROWHEAD PHARMA
Health Care·Biotechnology·UNITED STATES
$86.34
MCap $12.2B
as of 2026-09-04
Total
B3w
Fund
D3w
Quant
A10w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
+0.44
Sentiment 20.2%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$86.34
Adaptive Mean
$85.30
+1.04 vs mean
Adaptive σ
1.18
MIDOS BB
$82.94 – $87.67
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
-0.15
ROE
-55.2%
Z -0.54
Rev Gr
171.0%
Z -0.98
EPS Gr
—
Z +0.31
OPM Gr
370.2%
Z —
FCF Yld
-0.4%
Z +0.05
EPS Surp
-0.1%
Z +0.06
EPS 3mo Δ
-785.1%
Z +0.21
Fwd P/E
-17.87
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
6.98
Q6M
5.23
Q12M
10.45
MA 30/100
1.089
Bullish (MA30 > MA100)
α (Jensen)
0.6415
β (12M)
1.53
σ (12M)
0.613
Divergence — Fundamentals vs Momentum
Z Percentile
24%
Q Percentile
97%
Divergence
-73.2
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
21.5
RS Pctl
83%
RS Decile
D9
Persistence
3w
at grade B
Options / OI Analysis
as of 2026-09-04
OI Center
$83.65
-3.1% from spot
Max Pain
$80.00
PCR (OI)
0.67
neutral
Skew
-0.21
OI Composite
0
neutral
Direction
bearish